Skip to main content

Regeneron Pharmaceuticals, Inc 10-K for FY2021

Regeneron Pharmaceuticals, Inc. (REGN)

10-K 2022-02-07 For: 2021-12-31
View Original
Added on April 08, 2026

About this 10-K

Regeneron Pharmaceuticals, Inc filed this 10-K on February 7, 2022, covering the fiscal year ended December 31, 2021 (FY2021).

Headline figures

Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$16.07B
up 89.1% from $8.5B a year earlier
Net income
$8.08B
up 129.9% from net income of $3.51B a year earlier
Diluted EPS
$71.97
up 135.8% from $30.52 a year earlier